Consonance Capital Management’s Veracyte VCYT Stock Holding History

Consonance Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-46,752	Closed	-$362K	–	26
2016 Q4	$362K	Sell	46,752 -119,073	-72%	-$891K	0.04%	23
2016 Q3	$1.26M	Hold	165,825	–	–	0.12%	23
2016 Q2	$834K	Hold	165,825	–	–	0.12%	22
2016 Q1	$895K	Hold	165,825	–	–	0.14%	21
2015 Q4	$1.19M	Sell	165,825 -100,969	-38%	-$680K	0.16%	19
2015 Q3	$1.25M	Sell	266,794 -32,172	-11%	-$306K	0.18%	24
2015 Q2	$3.33M	Buy	298,966 +63,106	+27%	+$621K	0.33%	24
2015 Q1	$1.72M	Buy	+235,860	New	+$1.93M	0.16%	26

Other funds holding VCYT

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Consonance Capital Management's VCYT Position: Q1 2017 in Review

Consonance Capital Management sold out of Veracyte (VCYT) in Q1 2017, closing a stake of 46,752 shares — an estimated $362K sold.

Consonance Capital Management first reported a position in VCYT in Q1 2015 and held it in 8 quarters. The position peaked at $3.33M in Q2 2015. 84 funds tracked by Wall St. Rank hold VCYT as of Q1 2017.

Consonance Capital Management reported no remaining Veracyte position as of Q1 2017 after selling out during the quarter.
Consonance Capital Management sold 46,752 Veracyte shares in Q1 2017, an estimated $362K.
Consonance Capital Management first reported a position in Veracyte in Q1 2015 and held it in 8 quarters.
Consonance Capital Management's Veracyte position peaked at $3.33M in Q2 2015.
84 funds tracked by Wall St. Rank held Veracyte as of Q1 2017.

Based on Consonance Capital Management's 13F filing for Q1 2017, filed 15 May 2017.